Tokyo, July 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058603) titled 'A Study on the Association Between Alpha-2-glycoprotein 1 and Immune Checkpoint Inhibitor Resistance in Breast Cancer' on July 25.
Study Type:
Observational
Primary Sponsor:
Institute - Tokai University
Condition:
Condition - Breast Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study investigates the association between the expression of Alpha-2-glycoprotein 1 (ZAG) and therapeutic response in triple-negative breast cancer (TNBC) patients treated with immune checkpoint inhibitor (ICI)-based neoadjuvant chemotherapy (NAC). ZAG, secreted in an andr...